Baseline gut microbiota as a predictive marker for the efficacy of neoadjuvant chemotherapy in patients with early breast cancer: a multicenter prospective cohort study in the Setouchi Breast Project-14. - Nakamoto S; Kajiwara Y; Taniguchi K; Hida AI; Miyoshi Y; Kin T; Yamamoto M; Takabatake D; Kubo S; Hikino H; Ogasawara Y; Ikeda M; et al. (Breast cancer research and treatment, 2024)